Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis - A Pilot Study
Latest Information Update: 06 Mar 2023
At a glance
- Drugs AZD 1222 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 19 Mar 2021 Status changed from not yet recruiting to recruiting.
- 18 Mar 2021 New trial record